Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Cardiac Marker Tests Pipeline Market Report Overview

A cardiac marker test is a biomarker test used to diagnose cardiac diseases. The Cardiac Marker Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        Other Cardiac Marker Point of Care (POC) Tests

·        Troponin Point of Care (POC) Tests

·        Troponin Laboratory Tests

·        Brain Natriuretic Peptide (BNP) Point of Care (POC) Tests

·        Brain Natriuretic Peptide (BNP) Laboratory Tests

Key Territories ·        The US

·        Europe

·        Canada

·        China

·        Australia

Key Regulatory Paths ·        510(K)

·        CE

·        TGA

·        MDL

·        NMPA

Leading Companies ·        1Drop Diagnostics

·        3PrimeDx, Inc.

·        A/C Diagnostics LLC

·        Abbott Diagnostics

·        Abbott Point of Care Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cardiac Marker Tests Pipeline Market by Segments

The key segments in the Cardiac Marker Tests pipeline market are Other Cardiac Marker Point of Care (POC) Tests, Troponin Point of Care (POC) Tests, Troponin Laboratory Tests, Brain Natriuretic Peptide (BNP) Point of Care (POC) Tests, and Brain Natriuretic Peptide (BNP) Laboratory Tests among others. As of December 2023, Other Cardiac Marker Point of Care (POC) Tests accounted for the highest number of pipeline products. Other Cardiac Marker POC tests include CK-MB POC tests as well as Cardiac Panel tests, which include troponin, BNP, or CK-MB as one of their parameters.

Cardiac Marker Tests Pipeline Market Analysis by Segments, 2023 (%)

Cardiac Marker Tests Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Cardiac Marker Tests Pipeline Market

Download a Free Report Sample

Cardiac Marker Tests Pipeline Market Segmentation by Territories

A few of the key territories for Cardiac Marker Tests pipeline products are the US, Europe, Canada, China, and Australia among others. As of December 2023, the US accounted for the highest number of pipeline products.

Cardiac Marker Tests Pipeline Market Analysis by Territories, 2023 (%)

Cardiac Marker Tests Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Cardiac Marker Tests Pipeline Market

Download a Free Report Sample

Cardiac Marker Tests Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Cardiac Marker Tests pipeline market are 510(K), CE, TGA, MDL, and NMPA among others. As of December 2023, 510(K) was the most followed pathway for pipeline products in the market.

Cardiac Marker Tests Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Cardiac Marker Tests Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Cardiac Marker Tests Pipeline Market

Download a Free Report Sample

Cardiac Marker Tests Pipeline Market – Competitive Landscape

A few of the key companies associated with the Cardiac Marker Tests pipeline market are 1Drop Diagnostics, 3PrimeDx, Inc., A/C Diagnostics LLC, Abbott Diagnostics, and Abbott Point of Care Inc. among others.

Abbott Diagnostics (Abbott): Abbott is headquartered in Lake Forest, Illinois, the US. It is a manufacturer of in vitro diagnostic systems and tests. The company offers various core laboratory products, molecular POC products, transfusion medicine, professional services, and diagnostics. Abbott’s product portfolio includes laboratory systems for automation-molecular diagnostic systems and POC systems for blood analysis. The products are used in therapeutic drug monitoring, measurement of antibodies and antigens, and screening and diagnosis of cancer. Furthermore, Abbott serves blood banks, hospitals, commercial laboratories, government agencies, patient care testing sites, and plasma protein therapeutic companies.

Cardiac Marker Tests Pipeline Market Analysis by Companies, 2023

Cardiac Marker Tests Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Cardiac Marker Tests Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Cardiac Marker Tests Pipeline Market Segments Outlook

  • Other Cardiac Marker Point of Care (POC) Tests
  • Troponin Point of Care (POC) Tests
  • Troponin Laboratory Tests
  • Brain Natriuretic Peptide (BNP) Point of Care (POC) Tests
  • Brain Natriuretic Peptide (BNP) Laboratory Tests

Cardiac Marker Tests Pipeline Market Territories Outlook

  • The US
  • Europe
  • Canada
  • China
  • Australia

Cardiac Marker Tests Pipeline Market Regulatory Paths Outlook

  • 510(K)
  • CE
  • TGA
  • MDL
  • NMPA

Scope

This report provides:

  • Extensive coverage of the Cardiac Marker Tests under development.
  • An exhaustive list of major pipeline products and their details, including product descriptions, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Cardiac Marker Tests and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Gather actionable insights from competitor information to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Cardiac Marker Tests under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

1Drop Diagnostics
3PrimeDx, Inc.
A/C Diagnostics LLC
Abbott Diagnostics
Abbott Point of Care Inc
Abionic SA
Accel Diagnostics LLC
Access Bio Inc
ACS Biomarker
Adaltis Srl
AgPlus Diagnostics LTD
Akrivis Technologies LLC
Alere Inc
Alfa Wassermann Diagnostic Technologies, LLC
Alfa Wassermann Inc
All India Institute of Medical Sciences
Angle Biosciences Inc
Anteo Technologies Pty Ltd
Applied Proteomics Inc
Arrayit Corp (Inactive)
Arterez LLC
Aspira Womens Health Inc
Astute Medical Inc
Aterovax SA
Atonomics A/S (Inactive)
Axis-Shield Diagnostics Ltd
AXO Science SAS
Baker IDI Heart and Diabetes Institute
Baylor College of Medicine
BBB Technologies Inc
Beckman Coulter Inc
Behavioral Diagnostics Inc
Berg LLC
Bertis Inc
BG Medicine Inc
Bio Preventive Medicine Corp
Bio-AMD Inc
BioMedomics Inc
bioMerieux SA
Biosensia Ltd
Biostealth, Inc.
Biosurfit, SA
Biouniversa srl
Bluejay Diagnostics Inc
Boditech Med Inc
Boston Children's Hospital
British Heart Foundation
Canon Medical Systems Corp
Carclo Diagnostic Solutions Ltd
CardiNor AS
CardioGenics Inc
Cardior Pharmaceuticals GmbH
Carmel Diagnostics Ltd
Cavadis BV
Cedars-Sinai Medical Center
Cellgenex Diagnostics
ChemImage Corp
China Medical Technologies Inc (Inactive)
China Sky One Medical Inc
CHIP Diagnostics Inc
Cleveland Clinic
Co-Diagnostics Inc
Cordex Systems, LLC
Corgenix Medical Corp
CPD, LLC
Critical Diagnostics
DestiNA Genomics Ltd
Diagnorite Innovative Healthcare Pvt Ltd
Diagnos Inc
Diazyme Laboratories Inc
Diomune SL
DSC Technologies Inc
Duke University
Edan Instruments Inc
Edan Medical
ELITechGroup Inc
Emory University
Endothelium Scanning Nanotechnology Ltd
Epinex Diagnostics Inc
ET Healthcare Inc
Firalis SAS
Flinders University
French National Institute of Health and Medical Research
G Medical Health and Wellness
genedrive plc
Genesis Detection Systems, Inc.
Global Genomics Group LLC
GlyCardial Diagnostics SL
Grifols SA
Group K Diagnostics
Guangzhou Wondfo Biotech Co Ltd
Handok-Kalos Medical
Hannover Medical School
HealthCheck Diagonstics Inc
Hemex Health Inc
Hunan Lezhun Zhixin Biotechnology Co Ltd
Infigo Diagnostics Ltd (Inactive)
Inflammatix Inc
infYnity biomarkers S.A.S.
Insilicos LLC
Institute of Metabolic and Cardiovascular Diseases
Intelligent Optical Systems, Inc.
iXensor Co. Ltd.
Johns Hopkins University
Joslin Diabetes Center
KineMed Inc
Laboratory Corp of America Holdings
LeukoDx Ltd
LightDeck Diagnostics Inc
LumiraDx Ltd
MagBiosense Inc
Magnisense SAS
Mayo Clinic
MDNA Life Sciences Inc
Mediomics, LLC
MedMira Inc
Merck Millipore Corp
MetaboGen AB
Metanomics Health GmbH
MiRXES Pte Ltd
MML Ltd
MyCartis NV
Mylab Discovery Solutions Pvt Ltd
Nanomix Inc
Nanosphere Inc (Inactive)
National Center for Cardiovascular Research Carlos III
Neuome Peptides Pte Ltd
Nirmidas Biotech Inc
NorthShore University Health System
Nuclea Biotechnologies Inc. (Inactive)
Numares AG
Ohmx Corp
OPKO Health Inc
Orbit Genetics Inc
Ortho Clinical Diagnostics Holdings Plc
OSLER Diagnostics Ltd
Paperdrop Diagnostics SL
Parque Científico de Madrid
Persuasive BV
PixCell Medical Technologies Ltd
Prevencio Inc
Prognosys LLC
Prolight Diagnostics AB
Prolocor Inc.
Proplex Technologies Llc
Propria LLC
Proteome Sciences Plc
Proxim Diagnostics Corp
Psyros Diagnostics Ltd
Pulmokine Inc
QLIDA Diagnostics
Queen's University Belfast
Quidel Corp
Radiometer Medical ApS
Radisens Diagnostics Ltd
Randox Laboratories Ltd
Resdin Technologies Inc.
Rheonix Inc
Roche Diagnostics International Ltd
ROS Technologies, Inc
Salignostics Ltd
Sandia National Laboratories
Sarissa-Biomedical Ltd
SDIX LLC
Selfa, Inc.
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Shineco Inc
Siemens Healthcare Diagnostics Inc
Siemens Healthineers AG
Singulex Inc
SomaLogic Inc
Soroka University Medical Center
Sphingotec GmbH
SpinChip Diagnostics AS
Sree Chitra Tirunal Institute for Medical Sciences & Technology
StageZero Life Sciences Ltd
T2 Biosystems Inc
Tcoag Us Inc
Tethys Bioscience Inc (Inactive)
The Centre of Excellence for Prevention of Organ Failure
The University of British Columbia
Thermo Fisher Scientific Inc
ThreeFold Sensors (Inactive)
Tosoh Bioscience Inc
Trinity Biotech Plc
U.S. Department of Veterans Affairs
Unity Health Toronto
University College Dublin
University Hospital of Lyon
University of Adelaide
University of Alberta
University of Arizona
University of Birmingham
University of California San Diego
University of California San Francisco
University of Colorado
University of Connecticut
University of Illinois
University of Illinois at Chicago
University of Montreal
University of Nebraska
University of Nice Sophia Antipolis
University of Oslo
University of Otago
University of Pennsylvania
University of Saskatchewan
University of Texas Medical Branch at Galveston
University of Texas Southwestern Medical Center
University of Tokyo
University of Turku
University of Vermont
UpFront Diagnostics Ltd
Upstream Medical Technologies Ltd
vall d hebron institut de Recerca
Vega Russia
Washington University School of Medicine
XCellCure, LLC
Zymo Research Corp

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 14

|1.2 List of Figures 32

2 Introduction 33

2.1 Cardiac Marker Tests Overview 33

3 Products under Development 34

3.1 Cardiac Marker Tests – Pipeline Products by Stage of Development 34

3.2 Cardiac Marker Tests – Pipeline Products by Segment 35

3.3 Cardiac Marker Tests – Pipeline Products by Territory 36

3.4 Cardiac Marker Tests – Pipeline Products by Regulatory Path 37

3.5 Cardiac Marker Tests – Pipeline Products by Estimated Approval Date 38

3.6 Cardiac Marker Tests – Ongoing Clinical Trials 39

4 Cardiac Marker Tests – Pipeline Products under Development by Companies 40

4.1 Cardiac Marker Tests Companies – Pipeline Products by Stage of Development 40

4.2 Cardiac Marker Tests – Pipeline Products by Stage of Development 48

5 Cardiac Marker Tests Companies and Product Overview 57

5.1 1Drop Diagnostics Company Overview 57

5.1.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 57

5.2 3PrimeDx, Inc. Company Overview 59

5.2.1 3PrimeDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

5.3 A/C Diagnostics LLC Company Overview 60

5.3.1 A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 60

5.4 Abbott Diagnostics Company Overview 61

5.4.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 61

5.5 Abbott Point of Care Inc Company Overview 68

5.5.1 Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.6 Abionic SA Company Overview 69

5.6.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 69

5.7 Accel Diagnostics LLC Company Overview 72

5.7.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 72

5.8 Access Bio Inc Company Overview 73

5.8.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.9 ACS Biomarker Company Overview 74

5.9.1 ACS Biomarker Pipeline Products & Ongoing Clinical Trials Overview 74

5.10 Adaltis Srl Company Overview 75

5.10.1 Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 75

5.11 AgPlus Diagnostics LTD Company Overview 76

5.11.1 AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 76

5.12 Akrivis Technologies LLC Company Overview 77

5.12.1 Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 77

5.13 Alere Inc Company Overview 78

5.13.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.14 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 79

5.14.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 79

5.15 Alfa Wassermann Inc Company Overview 81

5.15.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.16 All India Institute of Medical Sciences Company Overview 83

5.16.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 83

5.17 Angle Biosciences Inc Company Overview 84

5.17.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.18 Anteo Technologies Pty Ltd Company Overview 85

5.18.1 Anteo Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 85

5.19 Applied Proteomics Inc Company Overview 86

5.19.1 Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.20 Arrayit Corp (Inactive) Company Overview 88

5.20.1 Arrayit Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 88

5.21 Arterez LLC Company Overview 89

5.21.1 Arterez LLC Pipeline Products & Ongoing Clinical Trials Overview 89

5.22 Aspira Womens Health Inc Company Overview 90

5.22.1 Aspira Womens Health Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.23 Astute Medical Inc Company Overview 91

5.23.1 Astute Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 91

5.24 Aterovax SA Company Overview 92

5.24.1 Aterovax SA Pipeline Products & Ongoing Clinical Trials Overview 92

5.25 Atonomics A/S (Inactive) Company Overview 95

5.25.1 Atonomics A/S (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95

5.26 Axis-Shield Diagnostics Ltd Company Overview 97

5.26.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 97

5.27 AXO Science SAS Company Overview 98

5.27.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 98

5.28 Baker IDI Heart and Diabetes Institute Company Overview 101

5.28.1 Baker IDI Heart and Diabetes Institute Pipeline Products & Ongoing Clinical Trials Overview 101

5.29 Baylor College of Medicine Company Overview 102

5.29.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 102

5.30 BBB Technologies Inc Company Overview 104

5.30.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 104

5.31 Beckman Coulter Inc Company Overview 112

5.31.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 112

5.32 Behavioral Diagnostics Inc Company Overview 116

5.32.1 Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.33 Berg LLC Company Overview 117

5.33.1 Berg LLC Pipeline Products & Ongoing Clinical Trials Overview 117

5.34 Bertis Inc Company Overview 118

5.34.1 Bertis Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.35 BG Medicine Inc Company Overview 119

5.35.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 119

5.36 Bio Preventive Medicine Corp Company Overview 120

5.36.1 Bio Preventive Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview 120

5.37 Bio-AMD Inc Company Overview 121

5.37.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 121

5.38 BioMedomics Inc Company Overview 124

5.38.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 124

5.39 bioMerieux SA Company Overview 125

5.39.1 bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 125

5.40 Biosensia Ltd Company Overview 126

5.40.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

5.41 Biostealth, Inc. Company Overview 127

5.41.1 Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127

5.42 Biosurfit, SA Company Overview 128

5.42.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 128

5.43 Biouniversa srl Company Overview 129

5.43.1 Biouniversa srl Pipeline Products & Ongoing Clinical Trials Overview 129

5.44 Bluejay Diagnostics Inc Company Overview 130

5.44.1 Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 130

5.45 Boditech Med Inc Company Overview 132

5.45.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 132

5.46 Boston Children’s Hospital Company Overview 133

5.46.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 133

5.47 British Heart Foundation Company Overview 134

5.47.1 British Heart Foundation Pipeline Products & Ongoing Clinical Trials Overview 134

5.48 Canon Medical Systems Corp Company Overview 135

5.48.1 Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 135

5.49 Carclo Diagnostic Solutions Ltd Company Overview 136

5.49.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

5.50 CardiNor AS Company Overview 137

5.50.1 CardiNor AS Pipeline Products & Ongoing Clinical Trials Overview 137

5.51 CardioGenics Inc Company Overview 138

5.51.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 138

5.52 Cardior Pharmaceuticals GmbH Company Overview 141

5.52.1 Cardior Pharmaceuticals GmbH Pipeline Products & Ongoing Clinical Trials Overview 141

5.53 Carmel Diagnostics Ltd Company Overview 142

5.53.1 Carmel Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 142

5.54 Cavadis BV Company Overview 143

5.54.1 Cavadis BV Pipeline Products & Ongoing Clinical Trials Overview 143

5.55 Cedars-Sinai Medical Center Company Overview 147

5.55.1 Cedars-Sinai Medical Center Pipeline Products & Ongoing Clinical Trials Overview 147

5.56 Cellgenex Diagnostics Company Overview 148

5.56.1 Cellgenex Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 148

5.57 ChemImage Corp Company Overview 149

5.57.1 ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 149

5.58 China Medical Technologies Inc (Inactive) Company Overview 150

5.58.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 150

5.59 China Sky One Medical Inc Company Overview 156

5.59.1 China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 156

5.60 CHIP Diagnostics Inc Company Overview 157

5.60.1 CHIP Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 157

5.61 Cleveland Clinic Company Overview 158

5.61.1 Cleveland Clinic Pipeline Products & Ongoing Clinical Trials Overview 158

5.62 Co-Diagnostics Inc Company Overview 159

5.62.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 159

5.63 Cordex Systems, LLC Company Overview 160

5.63.1 Cordex Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 160

5.64 Corgenix Medical Corp Company Overview 161

5.64.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 161

5.65 CPD, LLC Company Overview 164

5.65.1 CPD, LLC Pipeline Products & Ongoing Clinical Trials Overview 164

5.66 Critical Diagnostics Company Overview 165

5.66.1 Critical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 165

5.67 DestiNA Genomics Ltd Company Overview 167

5.67.1 DestiNA Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

5.68 Diagnorite Innovative Healthcare Pvt Ltd Company Overview 168

5.68.1 Diagnorite Innovative Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

5.69 Diagnos Inc Company Overview 169

5.69.1 Diagnos Inc Pipeline Products & Ongoing Clinical Trials Overview 169

5.70 Diazyme Laboratories Inc Company Overview 170

5.70.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 170

5.71 Diomune SL Company Overview 173

5.71.1 Diomune SL Pipeline Products & Ongoing Clinical Trials Overview 173

5.72 DSC Technologies Inc Company Overview 174

5.72.1 DSC Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 174

5.73 Duke University Company Overview 175

5.73.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 175

5.74 Edan Instruments Inc Company Overview 177

5.74.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 177

5.75 Edan Medical Company Overview 180

5.75.1 Edan Medical Pipeline Products & Ongoing Clinical Trials Overview 180

5.76 ELITechGroup Inc Company Overview 181

5.76.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 181

5.77 Emory University Company Overview 182

5.77.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 182

5.78 Endothelium Scanning Nanotechnology Ltd Company Overview 183

5.78.1 Endothelium Scanning Nanotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview 183

5.79 Epinex Diagnostics Inc Company Overview 184

5.79.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 184

5.80 ET Healthcare Inc Company Overview 185

5.80.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 185

5.81 Firalis SAS Company Overview 187

5.81.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 187

5.82 Flinders University Company Overview 190

5.82.1 Flinders University Pipeline Products & Ongoing Clinical Trials Overview 190

5.83 French National Institute of Health and Medical Research Company Overview 193

5.83.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 193

5.84 G Medical Health and Wellness Company Overview 195

5.84.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 195

5.85 genedrive plc Company Overview 196

5.85.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 196

5.86 Genesis Detection Systems, Inc. Company Overview 197

5.86.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 197

5.87 Global Genomics Group LLC Company Overview 199

5.87.1 Global Genomics Group LLC Pipeline Products & Ongoing Clinical Trials Overview 199

5.88 GlyCardial Diagnostics SL Company Overview 200

5.88.1 GlyCardial Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview 200

5.89 Grifols SA Company Overview 201

5.89.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 201

5.90 Group K Diagnostics Company Overview 202

5.90.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 202

5.91 Guangzhou Wondfo Biotech Co Ltd Company Overview 204

5.91.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 204

5.92 Handok-Kalos Medical Company Overview 207

5.92.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 207

5.93 Hannover Medical School Company Overview 208

5.93.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 208

5.94 HealthCheck Diagonstics Inc Company Overview 213

5.94.1 HealthCheck Diagonstics Inc Pipeline Products & Ongoing Clinical Trials Overview 213

5.95 Hemex Health Inc Company Overview 214

5.95.1 Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview 214

5.96 Hunan Lezhun Zhixin Biotechnology Co Ltd Company Overview 215

5.96.1 Hunan Lezhun Zhixin Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 215

5.97 Infigo Diagnostics Ltd (Inactive) Company Overview 216

5.97.1 Infigo Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 216

5.98 Inflammatix Inc Company Overview 217

5.98.1 Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview 217

5.99 infYnity biomarkers S.A.S. Company Overview 218

5.99.1 infYnity biomarkers S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 218

5.100 Insilicos LLC Company Overview 219

5.100.1 Insilicos LLC Pipeline Products & Ongoing Clinical Trials Overview 219

5.101 Institute of Metabolic and Cardiovascular Diseases Company Overview 220

5.101.1 Institute of Metabolic and Cardiovascular Diseases Pipeline Products & Ongoing Clinical Trials Overview 220

5.102 Intelligent Optical Systems, Inc. Company Overview 221

5.102.1 Intelligent Optical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 221

5.103 iXensor Co. Ltd. Company Overview 222

5.103.1 iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 222

5.104 Johns Hopkins University Company Overview 223

5.104.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 223

5.105 Joslin Diabetes Center Company Overview 226

5.105.1 Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 226

5.106 KineMed Inc Company Overview 227

5.106.1 KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 227

5.107 Laboratory Corp of America Holdings Company Overview 228

5.107.1 Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 228

5.108 LeukoDx Ltd Company Overview 229

5.108.1 LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 229

5.109 LightDeck Diagnostics Inc Company Overview 230

5.109.1 LightDeck Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 230

5.110 LumiraDx Ltd Company Overview 231

5.110.1 LumiraDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 231

5.111 MagBiosense Inc Company Overview 233

5.111.1 MagBiosense Inc Pipeline Products & Ongoing Clinical Trials Overview 233

5.112 Magnisense SAS Company Overview 234

5.112.1 Magnisense SAS Pipeline Products & Ongoing Clinical Trials Overview 234

5.113 Mayo Clinic Company Overview 235

5.113.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 235

5.114 MDNA Life Sciences Inc Company Overview 236

5.114.1 MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 236

5.115 Mediomics, LLC Company Overview 237

5.115.1 Mediomics, LLC Pipeline Products & Ongoing Clinical Trials Overview 237

5.116 MedMira Inc Company Overview 238

5.116.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 238

5.117 Merck Millipore Corp Company Overview 239

5.117.1 Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 239

5.118 MetaboGen AB Company Overview 240

5.118.1 MetaboGen AB Pipeline Products & Ongoing Clinical Trials Overview 240

5.119 Metanomics Health GmbH Company Overview 241

5.119.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 241

5.120 MiRXES Pte Ltd Company Overview 243

5.120.1 MiRXES Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 243

5.121 MML Ltd Company Overview 244

5.121.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 244

5.122 MyCartis NV Company Overview 246

5.122.1 MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview 246

5.123 Mylab Discovery Solutions Pvt Ltd Company Overview 249

5.123.1 Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 249

5.124 Nanomix Inc Company Overview 250

5.124.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 250

5.125 Nanosphere Inc (Inactive) Company Overview 251

5.125.1 Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 251

5.126 National Center for Cardiovascular Research Carlos III Company Overview 253

5.126.1 National Center for Cardiovascular Research Carlos III Pipeline Products & Ongoing Clinical Trials Overview 253

5.127 Neuome Peptides Pte Ltd Company Overview 254

5.127.1 Neuome Peptides Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 254

5.128 Nirmidas Biotech Inc Company Overview 255

5.128.1 Nirmidas Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 255

5.129 NorthShore University Health System Company Overview 256

5.129.1 NorthShore University Health System Pipeline Products & Ongoing Clinical Trials Overview 256

5.130 Nuclea Biotechnologies Inc. (Inactive) Company Overview 257

5.130.1 Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 257

5.131 Numares AG Company Overview 258

5.131.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview 258

5.132 Ohmx Corp Company Overview 260

5.132.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 260

5.133 OPKO Health Inc Company Overview 263

5.133.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 263

5.134 Orbit Genetics Inc Company Overview 265

5.134.1 Orbit Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 265

5.135 Ortho Clinical Diagnostics Holdings Plc Company Overview 266

5.135.1 Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 266

5.136 OSLER Diagnostics Ltd Company Overview 270

5.136.1 OSLER Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 270

5.137 Paperdrop Diagnostics SL Company Overview 271

5.137.1 Paperdrop Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview 271

5.138 Parque Científico de Madrid Company Overview 272

5.138.1 Parque Científico de Madrid Pipeline Products & Ongoing Clinical Trials Overview 272

5.139 Persuasive BV Company Overview 273

5.139.1 Persuasive BV Pipeline Products & Ongoing Clinical Trials Overview 273

5.140 PixCell Medical Technologies Ltd Company Overview 274

5.140.1 PixCell Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 274

5.141 Prevencio Inc Company Overview 275

5.141.1 Prevencio Inc Pipeline Products & Ongoing Clinical Trials Overview 275

5.142 Prognosys LLC Company Overview 276

5.142.1 Prognosys LLC Pipeline Products & Ongoing Clinical Trials Overview 276

5.143 Prolight Diagnostics AB Company Overview 277

5.143.1 Prolight Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 277

5.144 Prolocor Inc. Company Overview 279

5.144.1 Prolocor Inc. Pipeline Products & Ongoing Clinical Trials Overview 279

5.145 Proplex Technologies Llc Company Overview 280

5.145.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 280

5.146 Propria LLC Company Overview 281

5.146.1 Propria LLC Pipeline Products & Ongoing Clinical Trials Overview 281

5.147 Proteome Sciences Plc Company Overview 282

5.147.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 282

5.148 Proxim Diagnostics Corp Company Overview 283

5.148.1 Proxim Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 283

5.149 Psyros Diagnostics Ltd Company Overview 286

5.149.1 Psyros Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 286

5.150 Pulmokine Inc Company Overview 287

5.150.1 Pulmokine Inc Pipeline Products & Ongoing Clinical Trials Overview 287

5.151 QLIDA Diagnostics Company Overview 288

5.151.1 QLIDA Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 288

5.152 Queen’s University Belfast Company Overview 289

5.152.1 Queen’s University Belfast Pipeline Products & Ongoing Clinical Trials Overview 289

5.153 Quidel Corp Company Overview 292

5.153.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 292

5.154 Radiometer Medical ApS Company Overview 295

5.154.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview 295

5.155 Radisens Diagnostics Ltd Company Overview 296

5.155.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 296

5.156 Randox Laboratories Ltd Company Overview 297

5.156.1 Randox Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview 297

5.157 Resdin Technologies Inc. Company Overview 298

5.157.1 Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 298

5.158 Rheonix Inc Company Overview 299

5.158.1 Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview 299

5.159 Roche Diagnostics International Ltd Company Overview 300

5.159.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 300

5.160 ROS Technologies, Inc Company Overview 305

5.160.1 ROS Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 305

5.161 Salignostics Ltd Company Overview 306

5.161.1 Salignostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 306

5.162 Sandia National Laboratories Company Overview 307

5.162.1 Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview 307

5.163 Sarissa-Biomedical Ltd Company Overview 310

5.163.1 Sarissa-Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 310

5.164 SDIX LLC Company Overview 311

5.164.1 SDIX LLC Pipeline Products & Ongoing Clinical Trials Overview 311

5.165 Selfa, Inc. Company Overview 312

5.165.1 Selfa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 312

5.166 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 313

5.166.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 313

5.167 Shineco Inc Company Overview 316

5.167.1 Shineco Inc Pipeline Products & Ongoing Clinical Trials Overview 316

5.168 Siemens Healthcare Diagnostics Inc Company Overview 317

5.168.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 317

5.169 Siemens Healthineers AG Company Overview 322

5.169.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 322

5.170 Singulex Inc Company Overview 324

5.170.1 Singulex Inc Pipeline Products & Ongoing Clinical Trials Overview 324

5.171 SomaLogic Inc Company Overview 327

5.171.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 327

5.172 Soroka University Medical Center Company Overview 332

5.172.1 Soroka University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 332

5.173 Sphingotec GmbH Company Overview 333

5.173.1 Sphingotec GmbH Pipeline Products & Ongoing Clinical Trials Overview 333

5.174 SpinChip Diagnostics AS Company Overview 334

5.174.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 334

5.175 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 336

5.175.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 336

5.176 StageZero Life Sciences Ltd Company Overview 337

5.176.1 StageZero Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 337

5.177 T2 Biosystems Inc Company Overview 340

5.177.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 340

5.178 Tcoag Us Inc Company Overview 341

5.178.1 Tcoag Us Inc Pipeline Products & Ongoing Clinical Trials Overview 341

5.179 Tethys Bioscience Inc (Inactive) Company Overview 342

5.179.1 Tethys Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 342

5.180 The Centre of Excellence for Prevention of Organ Failure Company Overview 343

5.180.1 The Centre of Excellence for Prevention of Organ Failure Pipeline Products & Ongoing Clinical Trials Overview 343

5.181 The University of British Columbia Company Overview 345

5.181.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 345

5.182 Thermo Fisher Scientific Inc Company Overview 346

5.182.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 346

5.183 ThreeFold Sensors (Inactive) Company Overview 347

5.183.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 347

5.184 Tosoh Bioscience Inc Company Overview 348

5.184.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 348

5.185 Trinity Biotech Plc Company Overview 349

5.185.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 349

5.186 U.S. Department of Veterans Affairs Company Overview 351

5.186.1 U.S. Department of Veterans Affairs Pipeline Products & Ongoing Clinical Trials Overview 351

5.187 Unity Health Toronto Company Overview 352

5.187.1 Unity Health Toronto Pipeline Products & Ongoing Clinical Trials Overview 352

5.188 University College Dublin Company Overview 355

5.188.1 University College Dublin Pipeline Products & Ongoing Clinical Trials Overview 355

5.189 University Hospital of Lyon Company Overview 356

5.189.1 University Hospital of Lyon Pipeline Products & Ongoing Clinical Trials Overview 356

5.190 University of Adelaide Company Overview 357

5.190.1 University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview 357

5.191 University of Alberta Company Overview 358

5.191.1 University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 358

5.192 University of Arizona Company Overview 359

5.192.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 359

5.193 University of Birmingham Company Overview 360

5.193.1 University of Birmingham Pipeline Products & Ongoing Clinical Trials Overview 360

5.194 University of California San Diego Company Overview 361

5.194.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 361

5.195 University of California San Francisco Company Overview 362

5.195.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 362

5.196 University of Colorado Company Overview 363

5.196.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 363

5.197 University of Connecticut Company Overview 364

5.197.1 University of Connecticut Pipeline Products & Ongoing Clinical Trials Overview 364

5.198 University of Illinois Company Overview 366

5.198.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 366

5.199 University of Illinois at Chicago Company Overview 367

5.199.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 367

5.200 University of Montreal Company Overview 368

5.200.1 University of Montreal Pipeline Products & Ongoing Clinical Trials Overview 368

5.201 University of Nebraska Company Overview 369

5.201.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 369

5.202 University of Nice Sophia Antipolis Company Overview 370

5.202.1 University of Nice Sophia Antipolis Pipeline Products & Ongoing Clinical Trials Overview 370

5.203 University of Oslo Company Overview 371

5.203.1 University of Oslo Pipeline Products & Ongoing Clinical Trials Overview 371

5.204 University of Otago Company Overview 372

5.204.1 University of Otago Pipeline Products & Ongoing Clinical Trials Overview 372

5.205 University of Pennsylvania Company Overview 373

5.205.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 373

5.206 University of Saskatchewan Company Overview 375

5.206.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 375

5.207 University of Texas Medical Branch at Galveston Company Overview 376

5.207.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 376

5.208 University of Texas Southwestern Medical Center Company Overview 377

5.208.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 377

5.209 University of Tokyo Company Overview 378

5.209.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 378

5.210 University of Turku Company Overview 379

5.210.1 University of Turku Pipeline Products & Ongoing Clinical Trials Overview 379

5.211 University of Vermont Company Overview 382

5.211.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview 382

5.212 UpFront Diagnostics Ltd Company Overview 383

5.212.1 UpFront Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 383

5.213 Upstream Medical Technologies Ltd Company Overview 386

5.213.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 386

5.214 vall d hebron institut de Recerca Company Overview 394

5.214.1 vall d hebron institut de Recerca Pipeline Products & Ongoing Clinical Trials Overview 394

5.215 Vega Russia Company Overview 395

5.215.1 Vega Russia Pipeline Products & Ongoing Clinical Trials Overview 395

5.216 Washington University School of Medicine Company Overview 396

5.216.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 396

5.217 XCellCure, LLC Company Overview 397

5.217.1 XCellCure, LLC Pipeline Products & Ongoing Clinical Trials Overview 397

5.218 Zymo Research Corp Company Overview 400

5.218.1 Zymo Research Corp Pipeline Products & Ongoing Clinical Trials Overview 400

6 Cardiac Marker Tests- Recent Developments 401

6.1 Dec 13, 2023: Pfizer Provides Full-Year 2024 Guidance 401

6.2 Dec 07, 2023: Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference 404

6.3 Dec 05, 2023: Siemens Healthineers Appoints Vivek Kanade as New Head For Its Middle East and Africa Operations 404

6.4 Nov 30, 2023: Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors 405

6.5 Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes 405

6.6 Nov 27, 2023: Siemens Appoints Hakan Ozdemir as CEO of Smart Infrastructure in the Middle East 405

6.7 Nov 16, 2023: Censyn Secures NSF SBIR Grant and Arizona State Funding to Accelerate Commercialization of Innovative Neuro Health Medical Platform 405

6.8 Nov 15, 2023: StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update 406

6.9 Nov 13, 2023: UCD Appoints new Vice-President for Research, Innovation and Impact 407

6.10 Oct 30, 2023: Upfront Diagnostics conducts final trial phase for POC stroke test 408

6.11 Oct 28, 2023: Pfizer Q2 Results: Drug Maker’s Profit Declines 52% To Rs 149 Crore 408

6.12 Oct 24, 2023: Massachusetts General Hospital Researchers and Prevencio Announce AI-driven HART CVE Blood Test Accuracy for Patients with Coronary Chronic Total Occlusion 409

6.13 Oct 19, 2023: bioMérieux Makes Strategic Investment in Oxford Nanopore 409

6.14 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range 411

6.15 Oct 17, 2023: Johnson & Johnson Reports Q3 2023 Results 413

6.16 Oct 05, 2023: Beckman Coulter Receives 510(k) Clearance for Access CEA Immunoassay 414

6.17 Oct 04, 2023: Kellina Yarrish Joins Hazleton student Engagement Team as Associate Director 414

6.18 Sep 28, 2023: Pfizer Appoints New Chief IR Officer 415

6.19 Sep 28, 2023: Office of Entrepreneurship and Commercialization Appoints Two New Directors 415

6.20 Sep 11, 2023: Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific

Table

Cardiac Marker Tests – Pipeline Products by Stage of Development 33

Cardiac Marker Tests – Pipeline Products by Segment 34

Cardiac Marker Tests – Pipeline Products by Territory 35

Cardiac Marker Tests – Pipeline Products by Regulatory Path 36

Cardiac Marker Tests – Pipeline Products by Estimated Approval Date 37

Cardiac Marker Tests – Ongoing Clinical Trials 38

Cardiac Marker Tests Companies – Pipeline Products by Stage of Development 39

Cardiac Marker Tests – Pipeline Products by Stage of Development 47

1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 56

Apolipoprotein B (ApoB) Test – Product Status 56

Apolipoprotein B (ApoB) Test – Product Description 56

NT-proBNP Test – Product Status 56

NT-proBNP Test – Product Description 57

3PrimeDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

PulsePredic Test – Product Status 58

PulsePredic Test – Product Description 58

A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 59

Methionine Enzymatic Assay – Product Status 59

Methionine Enzymatic Assay – Product Description 59

Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 60

ARCHITECT c4000 System – High Sensitive Troponin-I Assay – Product Status 60

ARCHITECT c4000 System – High Sensitive Troponin-I Assay – Product Description 60

ARCHITECT c8000 Integrated System – Galectin-3 Assay – Product Status 61

ARCHITECT c8000 Integrated System – Galectin-3 Assay – Product Description 61

ARCHITECT c8000 System – High Sensitive Troponin-I Assay – Product Status 61

ARCHITECT c8000 System – High Sensitive Troponin-I Assay – Product Description 61

ARCHITECT ci16200 Integrated System – NT Pro BNP Assay – Product Status 62

ARCHITECT ci16200 Integrated System – NT Pro BNP Assay – Product Description 62

ARCHITECT ci4100 Integrated System – NT Pro BNP Assay – Product Status 62

ARCHITECT ci4100 Integrated System – NT Pro BNP Assay – Product Description 62

ARCHITECT i1000SR – NT Pro BNP Assay – Product Status 63

ARCHITECT i1000SR – NT Pro BNP Assay – Product Description 63

ARCHITECT i2000SR Integrated System – NT Pro BNP Assay – Product Status 63

ARCHITECT i2000SR Integrated System – NT Pro BNP Assay – Product Description 64

Abbott Diagnostics – Ongoing Clinical Trials Overview 65

ARCHITECT c8000 System – High Sensitive Troponin-I Assay – Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin 66

Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 67

i-STAT TnI-Nx – Product Status 67

i-STAT TnI-Nx – Product Description 67

Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 68

Point of Care Diagnostic Test – Acute Myocardial Infarction – Product Status 68

Point of Care Diagnostic Test – Acute Myocardial Infarction – Product Description 68

Point of Care Diagnostic Test – Cardiac Troponin I (cTnI) – Product Status 69

Point of Care Diagnostic Test – Cardiac Troponin I (cTnI) – Product Description 69

Point of Care Diagnostic Test – High Sensitive C-reactive Protein (hsCRP) – Product Status 69

Point of Care Diagnostic Test – High Sensitive C-reactive Protein (hsCRP) – Product Description 69

Point of Care Diagnostic Test – Pro B-type Natriuretic Peptide (ProBNP) – Product Status 70

Point of Care Diagnostic Test – Pro B-type Natriuretic Peptide (ProBNP) – Product Description 70

Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 71

pScreen BNP – Product Status 71

pScreen BNP – Product Description 71

Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 72

Rapid Diagnostic Test – Troponin I – Product Status 72

Rapid Diagnostic Test – Troponin I – Product Description 72

ACS Biomarker Pipeline Products & Ongoing Clinical Trials Overview 73

Multi-marker Heart Failure Assay – Product Status 73

Multi-marker Heart Failure Assay – Product Description 73

Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 74

CLIAgen Cardiac Marker Assay – Product Status 74

CLIAgen Cardiac Marker Assay – Product Description 74

AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 75

AgPlus Diagnostic System – Troponin I Assay – Product Status 75

AgPlus Diagnostic System – Troponin I Assay – Product Description 75

Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 76

Z-TECT – cTnI Assay – Product Status 76

Z-TECT – cTnI Assay – Product Description 76

Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Triage MPO Test – Product Status 77

Triage MPO Test – Product Description 77

Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 78

ACE Axcel System – Apo A1 Assay – Product Status 78

ACE Axcel System – Apo A1 Assay – Product Description 78

ACE Axcel System – Apo B Assay – Product Status 78

ACE Axcel System – Apo B Assay – Product Description 79

ACE Axcel System – HsCRP Assay – Product Status 79

ACE Axcel System – HsCRP Assay – Product Description 79

Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 80

ACE Alera Clinical Chemistry System – hsCRP – Product Status 80

ACE Alera Clinical Chemistry System – hsCRP – Product Description 80

ACE Axcel Clinical Chemistry System – hsCRP – Product Status 80

ACE Axcel Clinical Chemistry System – hsCRP – Product Description 81

All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 82

Biomarker Test – Cardiac Arrest – Product Status 82

Biomarker Test – Cardiac Arrest – Product Description 82

Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Cardiac Troponin Biomarker Kit – Product Status 83

Cardiac Troponin Biomarker Kit – Product Description 83

Anteo Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

AtomoRapid – Heart Attack – Product Status 84

AtomoRapid – Heart Attack – Product Description 84

Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 85

API Diagnostic Test – Cardiovascular Disease – Product Status 85

API Diagnostic Test – Cardiovascular Disease – Product Description 85

SimpliPro Cardiac – Product Status 85

SimpliPro Cardiac – Product Description 86

Arrayit Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 87

Companion Diagnostic Test – Plavix – Product Status 87

Companion Diagnostic Test – Plavix – Product Description 87

Arterez LLC Pipeline Products & Ongoing Clinical Trials Overview 88

GlycoCardia Companion Diagnostic Test – Product Status 88

GlycoCardia Companion Diagnostic Test – Product Description 88

Aspira Womens Health Inc Pipeline Products & Ongoing Clinical Trials Overview 89

VASCLIR – Product Status 89

VASCLIR – Product Description 89

Astute Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 90

Diagnostic Test – Acute Coronary Syndrome – Product Status 90

Diagnostic Test – Acute Coronary Syndrome – Product Description 90

Aterovax SA Pipeline Products & Ongoing Clinical Trials Overview 91

AteroDx Combo – Product Status 91

AteroDx Combo – Product Description 91

AteroDx ISO – Product Status 91

AteroDx ISO – Product Description 92

sPLA2 Atherosclerosis Test – Asymptomatic Patients – Product Status 92

sPLA2 Atherosclerosis Test – Asymptomatic Patients – Product Description 92

Atonomics A/S (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93

Premium Trace – B-Type Natriuretic Peptide Assay – Product Status 93

Premium Trace – B-Type Natriuretic Peptide Assay – Product Description 93

Trace – D-Dimer Test – Product Status 93

Trace – D-Dimer Test – Product Description 94

Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

Afinion hsCRP Assay – Product Status 95

Afinion hsCRP Assay – Product Description 95

AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 96

Multiplexed Detection – BNP – Product Status 96

Multiplexed Detection – BNP – Product Description 96

Multiplexed Detection – Myoglobin – Product Status 96

Multiplexed Detection – Myoglobin – Product Description 97

Multiplexed Detection – Troponin – Product Status 97

Multiplexed Detection – Troponin – Product Description 97

Baker IDI Heart and Diabetes Institute Pipeline Products & Ongoing Clinical Trials Overview 98

Blood Test – Heart Attack – Product Status 98

Blood Test – Heart Attack – Product Description 98

Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 99

Lipid Blood Test – Heart Attack – Product Status 99

Lipid Blood Test – Heart Attack – Product Description 99

Lipid Blood Test – Stroke – Product Status 99

Lipid Blood Test – Stroke – Product Description 100

BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 101

Mark-B – D-dimer Test – Product Status 101

Mark-B – D-dimer Test – Product Description 101

Mark-B – Myoglobin Test – Product Status 102

Mark-B – Myoglobin Test – Product Description 102

MarkB – CK-MB Test – Product Status 102

MarkB – CK-MB Test – Product Description 103

MarkB – cTnl Test – Product Status 103

MarkB – cTnl Test – Product Description 103

MarkB – Galectin-3 Test – Product Status 104

MarkB – Galectin-3 Test – Product Description 104

MarkB – hsCRP Test – Product Status 105

MarkB – hsCRP Test – Product Description 105

MarkB – NT-proBNP Test – Product Status 105

MarkB – NT-proBNP Test – Product Description 106

MarkB – ST2 Test – Product Status 106

MarkB – ST2 Test – Product Description 106

Mobile RDT Reader – Troponin-I Test – Product Status 107

Mobile RDT Reader – Troponin-I Test – Product Description 107

Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 108

SYNCHRON LXi 725 Anti-Cardiolipin Assay – Product Status 108

SYNCHRON LXi 725 Anti-Cardiolipin Assay – Product Description 108

SYNCHRON LXi 725 Ischemia Modified Albumin Assay – Product Status 109

SYNCHRON LXi 725 Ischemia Modified Albumin Assay – Product Description 109

UniCel DxC 600i Synchron Access – ß2-Glycoprotein 1 Ab Assay – Product Status 109

UniCel DxC 600i Synchron Access – ß2-Glycoprotein 1 Ab Assay – Product Description 109

UniCel DxI 600 Access Immunoassay System – hsTnI Assay – Product Status 110

UniCel DxI 600 Access Immunoassay System – hsTnI Assay – Product Description 110

UniCel DxI 800 Access Immunoassay System – hsTnI Assay – Product Status 110

UniCel DxI 800 Access Immunoassay System – hsTnI Assay – Product Description 110

Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 112

Epigenetic Test – Cardiovascular Disease – Product Status 112

Epigenetic Test – Cardiovascular Disease – Product Description 112

Berg LLC Pipeline Products & Ongoing Clinical Trials Overview 113

Multi-Analyte Diagnostic Assay – Heart Failure – Product Status 113

Multi-Analyte Diagnostic Assay – Heart Failure – Product Description 113

Bertis Inc Pipeline Products & Ongoing Clinical Trials Overview 114

Proteomic-Based Biomarker Test – Cardiovascular Disease – Product Status 114

Proteomic-Based Biomarker Test – Cardiovascular Disease – Product Description 114

BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 115

BGM Galectin-3 Test – Adverse Cardiovascular Events – Product Status 115

BGM Galectin-3 Test – Adverse Cardiovascular Events – Product Description 115

Bio Preventive Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview 116

Diagnostic Test – Heart Diseases – Product Status 116

Diagnostic Test – Heart Diseases – Product Description 116

Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 117

Magnetic Immunoassay Detection System – Cardiac Myoglobin – Product Status 117

Magnetic Immunoassay Detection System – Cardiac Myoglobin – Product Description 117

Magnetic Immunoassay Detection System – Cardiac Troponin – Product Status 118

Magnetic Immunoassay Detection System – Cardiac Troponin – Product Description 118

Magnetic Immunoassay Detection System – CK MB – Product Status 118

Magnetic Immunoassay Detection System – CK MB – Product Description 118

BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 120

Point of Care Test – Troponin – Product Status 120

Point of Care Test – Troponin – Product Description 120

bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 121

Vidas hsCRP Assay – Product Status 121

Vidas hsCRP Assay – Product Description 121

Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

RapiPlex – Myoglobin Assay – Product Status 122

RapiPlex – Myoglobin Assay – Product Description 122

Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview 123

Point-Of-Care Assay – B-Type Natriuretic Peptide – Product Status 123

Point-Of-Care Assay – B-Type Natriuretic Peptide – Product Description 123

Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 124

Spinit – D-dimer Test – Product Status 124

Spinit – D-dimer Test – Product Description 124

Biouniversa srl Pipeline Products & Ongoing Clinical Trials Overview 125

BAG3 ELISA – Cardiovascular Disease – Product Status 125

BAG3 ELISA – Cardiovascular Disease – Product Description 125

Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 126

Symphony hsTNT/I – Product Status 126

Symphony hsTNT/I – Product Description 126

Symphony NT-pro BNP – Product Status 127

Symphony NT-pro BNP – Product Description 127

Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 128

Ichroma 10 – ST2 Assay – Product Status 128

Ichroma 10 – ST2 Assay – Product Description 128

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 129

Biomarker Panel – Cardiac Allograft Vasculopathy – Product Status 129

Biomarker Panel – Cardiac Allograft Vasculopathy – Product Description 129

British Heart Foundation Pipeline Products & Ongoing Clinical Trials Overview 130

Diagnostic Blood Test – Heart Attack – Product Status 130

Diagnostic Blood Test – Heart Attack – Product Description 130

Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 131

Diagnostic Test – Heart Disease – Product Status 131

Diagnostic Test – Heart Disease – Product Description 131

Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

Micropoc-pro – Troponin-I Assay – Product Status 132

Micropoc-pro – Troponin-I Assay – Product Description 132

CardiNor AS Pipeline Products & Ongoing Clinical Trials Overview 133

Secretoneurin ELISA Assay – Product Status 133

Secretoneurin ELISA Assay – Product Description 133

CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 134

Heart Failure Genomics Risk Test – Product Status 134

Heart Failure Genomics Risk Test – Product Description 134

Heart Failure Risk Stratification Test – Product Status 135

Heart Failure Risk Stratification Test – Product Description 135

Troponin-I Test – Product Status 135

Troponin-I Test – Product Description 135

Cardior Pharmaceuticals GmbH Pipeline Products & Ongoing Clinical Trials Overview 137

Companion Diagnostic Assay – Heart Failure – Product Status 137

Companion Diagnostic Assay – Heart Failure – Product Description 137

Carmel Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 138

TCL-HF – Product Status 138

TCL-HF – Product Description 138

Cavadis BV Pipeline Products & Ongoing Clinical Trials Overview 139

CAVARISK CAD – Product Status 139

CAVARISK CAD – Product Description 139

CAVARISK CVD – Product Status 140

CAVARISK CVD – Product Description 140

Prognostic Test – Myocardial Infarction – Product Status 140

Prognostic Test – Myocardial Infarction – Product Description 140

Prognostic Test – Peripheral Artery Disease – Product Status 141

Prognostic Test – Peripheral Artery Disease – Product Description 141

Prognostic Test – Stroke – Product Status 141

Prognostic Test – Stroke – Product Description 141

Cedars-Sinai Medical Center Pipeline Products & Ongoing Clinical Trials Overview 143

BIN1 Heart Failure Test – Product Status 143

BIN1 Heart Failure Test – Product Description 143

Cellgenex Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 144

CardioStent Test – Product Status 144

CardioStent Test – Product Description 144

ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 145

Diagnostic Test – Heart Failure – Product Status 145

Diagnostic Test – Heart Failure – Product Description 145

China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 146

Cardiac Diseases Reagent Test Kit – ECLIA Analyzer – Product Status 146

Cardiac Diseases Reagent Test Kit – ECLIA Analyzer – Product Description 146

Diagnostic Assay – C-Reactive Protein – Product Status 147

Diagnostic Assay – C-Reactive Protein – Product Description 147

Diagnostic Assay – Cardiac Troponin I – Product Status 147

Diagnostic Assay – Cardiac Troponin I – Product Description 147

Diagnostic Assay – Creatine Kinase-MB Isoenzyme – Product Status 148

Diagnostic Assay – Creatine Kinase-MB Isoenzyme – Product Description 148

Diagnostic Assay – Fatty Acid Binding Protein – Product Status 148

Diagnostic Assay – Fatty Acid Binding Protein – Product Description 149

Diagnostic Assay – Myoglobin – Product Status 149

Diagnostic Assay – Myoglobin – Product Description 149

Diagnostic Assay – N-Terminal-Human – Product Status 150

Diagnostic Assay – N-Terminal-Human – Product Description 150

China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 151

Diagnostic Kit – Sudden Cardiac Death – Product Status 151

Diagnostic Kit – Sudden Cardiac Death – Product Description 151

CHIP Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 152

ExoTENPO – Cardiac Trauma Assay – Product Status 152

ExoTENPO – Cardiac Trauma Assay – Product Description 152

Cleveland Clinic Pipeline Products & Ongoing Clinical Trials Overview 153

Corin Assay – Congestive Heart Failure – Product Status 153

Corin Assay – Congestive Heart Failure – Product Description 153

Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 154

Diagnostic Test – Heart Disease – Product Status 154

Diagnostic Test – Heart Disease – Product Description 154

Cordex Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 155

SmartCuff – Product Status 155

SmartCuff – Product Description 155

Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 156

Atherosclerosis Diagnostic Test – LDT – Product Status 156

Atherosclerosis Diagnostic Test – LDT – Product Description 156

AtherOx Test Kit – Product Status 157

AtherOx Test Kit – Product Description 157

Gen-2 Version AtherOx Test Kit – Product Status 157

Gen-2 Version AtherOx Test Kit – Product Description 157

Serum Amyloid Protein Biomarker Test – Product Status 158

Serum Amyloid Protein Biomarker Test – Product Description 158

CPD, LLC Pipeline Products & Ongoing Clinical Trials Overview 159

OxLDL – Product Status 159

OxLDL – Product Description 159

Critical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 160

Presage ST2 Assay – Automated Platform – Product Status 160

Presage ST2 Assay – Automated Platform – Product Description 160

sNEP Biomarker Test – Heart Failure – Product Status 160

sNEP Biomarker Test – Heart Failure – Product Description 161

DestiNA Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 162

Biomarker Diagnostic Assay – Heart Disease – Product Status 162

Biomarker Diagnostic Assay – Heart Disease – Product Description 162

Diagnorite Innovative Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 163

Diagnostic Kit – Acute Myocardial Infarction – Product Status 163

Diagnostic Kit – Acute Myocardial Infarction – Product Description 163

Diagnos Inc Pipeline Products & Ongoing Clinical Trials Overview 164

Diagnostic Test – Cardiovascular And Metabolic Diseases – Product Status 164

Diagnostic Test – Cardiovascular And Metabolic Diseases – Product Description 164

Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 165

ProADM Test – Product Status 165

ProADM Test – Product Description 165

ProANP Test – Product Status 166

ProANP Test – Product Description 166

ProET1 Test – Product Status 166

ProET1 Test – Product Description 166

Diomune SL Pipeline Products & Ongoing Clinical Trials Overview 168

SEPSISpredict – Product Status 168

SEPSISpredict – Product Description 168

DSC Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 169

Point-Of-Care Blood Plasma Assay – Product Status 169

Point-Of-Care Blood Plasma Assay – Product Description 169

Duke University Pipeline Products & Ongoing Clinical Trials Overview 170

Anticoagulation And Thrombosis Point Of Care Test (AT-POCT) – Product Status 170

Anticoagulation And Thrombosis Point Of Care Test (AT-POCT) – Product Description 170

Biomarker Test – Heart Failure – Product Status 171

Biomarker Test – Heart Failure – Product Description 171

Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 172

CT3 – BNP Assay – Product Status 172

CT3 – BNP Assay – Product Description 172

CT3 – CK-MB Assay – Product Status 173

CT3 – CK-MB Assay – Product Description 173

CT3 – Myo Assay – Product Status 173

CT3 – Myo Assay – Product Description 173

m16 – D-dimer Assay – Product Status 174

m16 – D-dimer Assay – Product Description 174

Edan Medical Pipeline Products & Ongoing Clinical Trials Overview 175

m16 – CRP Assay – Product Status 175

m16 – CRP Assay – Product Description 175

ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 176

Eon High Sensitivity C-reactive Protein (hsCRP) Assay – Product Status 176

Eon High Sensitivity C-reactive Protein (hsCRP) Assay – Product Description 176

Emory University Pipeline Products & Ongoing Clinical Trials Overview 177

Diagnostic Test – Coronary Artery Disease – Product Status 177

Diagnostic Test – Coronary Artery Disease – Product Description 177

Endothelium Scanning Nanotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview 178

Companion Diagnostic – Heart Failure – Product Status 178

Companion Diagnostic – Heart Failure – Product Description 178

Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 179

Epinex G1A – Coronary Artery Disease Rapid Diagnostic Test – Product Status 179

Epinex G1A – Coronary Artery Disease Rapid Diagnostic Test – Product Description 179

ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 180

Pylon Assay – High-Sensitivity C-reactive Protein – Product Status 180

Pylon Assay – High-Sensitivity C-reactive Protein – Product Description 180

Pylon Assay – NT-ProBNP – Product Status 181

Pylon Assay – NT-ProBNP – Product Description 181

Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 182

Diagnostic Assay – Cardiovascular Diseases – Product Status 182

Diagnostic Assay – Cardiovascular Diseases – Product Description 182

Diagnostic Kit – Acute Myocardial Infarction – Product Status 183

Diagnostic Kit – Acute Myocardial Infarction – Product Description 183

Diagnostic Panel – Vasculitis – Product Status 183

Diagnostic Panel – Vasculitis – Product Description 183

Flinders University Pipeline Products & Ongoing Clinical Trials Overview 185

Cardiac Troponin Blood Test – Product Status 185

Cardiac Troponin Blood Test – Product Description 185

Flinders University – Ongoing Clinical Trials Overview 186

Cardiac Troponin Blood Test – Rapid Assessment of Possible ACS In the emergency Department with High Sensitivity Troponin T (RAPID-TnT): Improving Decision-Making in the Face of Uncertainty: A Randomized trial of 0/1 hour High-Sensitivity Troponin in the investigation of Suspected ACS 187

French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 188

Biomarker Based Assay – Atherosclerosis – Product Status 188

Biomarker Based Assay – Atherosclerosis – Product Description 188

Biomarker Based Assay – Cardiovascular Disease – Product Status 188

Biomarker Based Assay – Cardiovascular Disease – Product Description 189

G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 190

Heart Health Test – Product Status 190

Heart Health Test – Product Description 190

genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 191

Genedrive – Stroke Marker Test – Product Status 191

Genedrive – Stroke Marker Test – Product Description 191

Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 192

Diagnostic Test – Arteriosclerosis – Product Status 192

Diagnostic Test – Arteriosclerosis – Product Description 192

Diagnostic Test – Hypertension – Product Status 192

Diagnostic Test – Hypertension – Product Description 193

Global Genomics Group LLC Pipeline Products & Ongoing Clinical Trials Overview 194

KnowPLAQUE – Product Status 194

KnowPLAQUE – Product Description 194

GlyCardial Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview 195

Diagnostic Test – Cardiac Ischemia – Product Status 195

Diagnostic Test – Cardiac Ischemia – Product Description 195

Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 196

Diagnostic Test – Cardiovascular Diseases – Product Status 196

Diagnostic Test – Cardiovascular Diseases – Product Description 196

Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 197

Multidiagnostic – BNP Test – Product Status 197

Multidiagnostic – BNP Test – Product Description 197

Multidiagnostic – Troponin T And I Test – Product Status 198

Multidiagnostic – Troponin T And I Test – Product Description 198

Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 199

Accre Diagnostic Assay – Galectin-3 – Product Status 199

Accre Diagnostic Assay – Galectin-3 – Product Description 199

Accre Diagnostic Assay – GDF-15 – Product Status 200

Accre Diagnostic Assay – GDF-15 – Product Description 200

Finecare Diagnostic Assay – ST2 – Product Status 200

Finecare Diagnostic Assay – ST2 – Product Description 201

Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 202

Nanocon RST Kit – Cardiovascular Disease – Product Status 202

Nanocon RST Kit – Cardiovascular Disease – Product Description 202

Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 203

Diagnostic Assay – Takotsubo Cardiomyopathy – Product Status 203

Diagnostic Assay – Takotsubo Cardiomyopathy – Product Description 203

Diagnostic Marker – Peripartum Cardiomyopathy – Product Status 204

Diagnostic Marker – Peripartum Cardiomyopathy – Product Description 204

lncRNA LIPCAR – Heart Failure – Product Status 204

lncRNA LIPCAR – Heart Failure – Product Description 204

Hannover Medical School – Ongoing Clinical Trials Overview 206

lncRNA LIPCAR – Heart Failure – A Non-interventional Patient Study to Demonstrate Medical Utility of the lncRNA to Predict HF in AMI Patients 207

HealthCheck Diagonstics Inc Pipeline Products & Ongoing Clinical Trials Overview 208

HeartDetect – Product Status 208

HeartDetect – Product Description 208

Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview 209

Point Of Care Device – Cardiovascular Diseases – Product Status 209

Point Of Care Device – Cardiovascular Diseases – Product Description 209

Hunan Lezhun Zhixin Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

Myocardial Marker Kit – Product Status 210

Myocardial Marker Kit – Product Description 210

Infigo Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 211

MIPdx-BNP – Product Status 211

MIPdx-BNP – Product Description 211

Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview 212

Diagnostic Test – Myocardial Infarction – Product Status 212

Diagnostic Test – Myocardial Infarction – Product Description 212

infYnity biomarkers S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 213

Cardiovascular Test – Product Status 213

Cardiovascular Test – Product Description 213

Insilicos LLC Pipeline Products & Ongoing Clinical Trials Overview 214

PreClue Diagnostic Test – Cardiovascular Disease – Product Status 214

PreClue Diagnostic Test – Cardiovascular Disease – Product Description 214

Institute of Metabolic and Cardiovascular Diseases Pipeline Products & Ongoing Clinical Trials Overview 215

Diagnostic Biomarker – Atherosclerosis – Product Status 215

Diagnostic Biomarker – Atherosclerosis – Product Description 215

Intelligent Optical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 216

Quantum Dot – Test Strip – Product Status 216

Quantum Dot – Test Strip – Product Description 216

iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 217

Cardiac Enzymes Test – Product Status 217

Cardiac Enzymes Test – Product Description 217

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 218

Biomarker Assay – Myocardial Ischemia – Product Status 218

Biomarker Assay – Myocardial Ischemia – Product Description 218

Cardiac Troponin I Assay – Product Status 218

Cardiac Troponin I Assay – Product Description 219

Diagnostic Assay – Myocardial Ischemia – Product Status 219

Diagnostic Assay – Myocardial Ischemia – Product Description 219

Diagnostic Assay – Pulmonary Arterial Hypertension – Product Status 220

Diagnostic Assay – Pulmonary Arterial Hypertension – Product Description 220

Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 221

Cardiac Biomarker Assay – Myocardial Infarction – Product Status 221

Cardiac Biomarker Assay – Myocardial Infarction – Product Description 221

KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 222

Diagnostic Assay – Myocardial Fibrosis – Product Status 222

Diagnostic Assay – Myocardial Fibrosis – Product Description 222

Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 223

Vantera Assay – Cardiovascular Diseases – Product Status 223

Vantera Assay – Cardiovascular Diseases – Product Description 223

LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 224

Accellix Disposable Cartridges Test – Heart Disease – Product Status 224

Accellix Disposable Cartridges Test – Heart Disease – Product Description 224

LightDeck Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 225

Rapid Assay – Chest Pain Assessment – Product Status 225

Rapid Assay – Chest Pain Assessment – Product Description 225

LumiraDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 226

LumiraDx – BNP – Product Status 226

LumiraDx – BNP – Product Description 226

LumiraDx – High Sensitivity Troponin I Test – Product Status 227

LumiraDx – High Sensitivity Troponin I Test – Product Description 227

MagBiosense Inc Pipeline Products & Ongoing Clinical Trials Overview 228

Rapid Assay – Heart Attack – Product Status 228

Rapid Assay – Heart Attack – Product Description 228

Magnisense SAS Pipeline Products & Ongoing Clinical Trials Overview 229

Emergency Diagnostic Test – Cardiovascular Diseases – Product Status 229

Emergency Diagnostic Test – Cardiovascular Diseases – Product Description 229

Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 230

Diagnostic Test – Aortic Valve And Vessel Stenosis – Product Status 230

Diagnostic Test – Aortic Valve And Vessel Stenosis – Product Description 230

MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 231

Mitomic Test – Cardiovascular Diseases – Product Status 231

Mitomic Test – Cardiovascular Diseases – Product Description 231

Mediomics, LLC Pipeline Products & Ongoing Clinical Trials Overview 232

Diagnostic Test – Cardiovascular Diseases – Product Status 232

Diagnostic Test – Cardiovascular Diseases – Product Description 232

MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 233

HH Marker Chronic Disease Monitoring Test – Cardiac Multiplex B – Product Status 233

HH Marker Chronic Disease Monitoring Test – Cardiac Multiplex B – Product Description 233

Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 234

SMC sd-LDL Test – Product Status 234

SMC sd-LDL Test – Product Description 234

MetaboGen AB Pipeline Products & Ongoing Clinical Trials Overview 235

Diagnostic Test – Atherosclerosis – Product Status 235

Diagnostic Test – Atherosclerosis – Product Description 235

Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 236

Diagnostic Assay – Congestive Heart Failure – Product Status 236

Diagnostic Assay – Congestive Heart Failure – Product Description 236

Prognostic Assay – Congestive Heart Failure – Product Status 236

Prognostic Assay – Congestive Heart Failure – Product Description 237

MiRXES Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 238

CD

Figures

Cardiac Marker Tests – Pipeline Products by Stage of Development 34_x000D_

Cardiac Marker Tests – Pipeline Products by Segment 35_x000D_

Cardiac Marker Tests – Pipeline Products by Territory 36_x000D_

Cardiac Marker Tests – Pipeline Products by Regulatory Path 37_x000D_

Cardiac Marker Tests – Pipeline Products by Estimated Approval Date 38_x000D_

Cardiac Marker Tests – Ongoing Clinical Trials 39_x000D_

Frequently asked questions

Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.